Table 3.
Spearman’s rho correlation coefficients among plasma levels of lipid metabolites and HFGS of GBS patients at nadir and at discharge.
| HFGS at nadir | HFGS at discharge | |
|---|---|---|
| PCaa C40:2 | −0.35* | −0.21 |
| PCaa C42:2 | −0.43** | −0.29 |
| PCae C34:0 | −0.39* | −0.35* |
| PCae C36:0 | −0.24 | −0.14 |
| PCae C40:1 | −0.38* | −0.28 |
| PCae C40:2 | −0.23 | −0.14 |
| PCae C40:3 | −0.37* | −0.27 |
| PCae C40:4 | −0.44 ** | −0.30 |
| PCae C42:2 | −0.40* | −0.36* |
| PCae C42:3 | −0.48** | −0.40* |
| PCae C44:3 | −0.30 | −0.16 |
| SM C24:0 | −0.46** | −0.39* |
*Correlation is significant at the 0.05 level.
**Correlation is significant at the 0.01 level.